Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000277.2(PAH):c.523C>T (p.Pro175Ser)

CA16020810

555366 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 668b6965-0eb2-46ca-a2a6-80d7f55a3bf1

HGVS expressions

NM_000277.2:c.523C>T

NM_000277.2(PAH):c.523C>T (p.Pro175Ser)

NC_000012.12:g.102855319G>A

CM000674.2:g.102855319G>A

NC_000012.11:g.103249097G>A

CM000674.1:g.103249097G>A

NC_000012.10:g.101773227G>A

NG_008690.1:g.67284C>T

NG_008690.2:g.108092C>T

NM_000277.1:c.523C>T

NM_001354304.1:c.523C>T

NM_000277.3:c.523C>T

ENST00000307000.7:c.508C>T

ENST00000549111.5:n.619C>T

ENST00000551988.5:n.544C>T

ENST00000553106.5:c.523C>T

Likely Pathogenic

PP3 PM2 PP4_Moderate PM3

Evidence Links 1

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.523C>T (p.Pro175Ser) variant in PAH has been reported in 1 individual with classic PKU (BH4 deficiency excluded) in trans with pathogenic variant p.R413P (PP4_Moderate, PM3; PMID: 26322415). This variant is absent in population databases (PM2). Computational evidence support a deleterious effect (PP3). In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PM2, PM3, PP3.

PP3

Multiple lines of computational evidence support a deleterious effect (SIFT, Polyphen2, MutationTaster, REVEL=0.851)

PM2

Absent from controls in ExAC/gnomAD, 1000 Genomes, ESP

PP4_Moderate

P175S detected in a patient with classic PKU. BH4 deficiency was excluded. PMID: 26322415

P175S detected in a patient with classic PKU. All patients fulfilled the diagnostic criteria of PKU, with a blood phenylalanine concentration >2 mg/dl. BH4 deficiency was excluded by analysis of urinary pterins and dihydropteridine reductase activity in erythrocytes. PubMed:26322415

PM3

detected in trans with p.R413P (P, 6 submitters) PMID: 26322415

Patient genotype: c.[523C>T ];[1238G>C], p.[P175S];[R413P]. All mutations identified in patients were confirmed by analyzing parental DNA. When mutation loci were detected in patients, the same locus of the parental sample was amplified by PCR and analyzed by Sanger automated sequencing. PubMed:26322415

Approved on: 2019-04-08

Published on: 2019-04-08

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.